GingiPro™

We are proud to share a targeted, feline-specific medication for Feline Chronic Gingivostomatitis that delivers antiviral, anti-inflammatory, and antimicrobial support in one precision-based treatment.

NEW therapy for Cats NOW AVAILABLE!

Tune in for Our Free FCGS Webinar!

March 24 | 8 p.m. ET

RACE-Approved CE Credit Hours: 1
Free to attend

This webinar reviews Feline Chronic Gingivostomatitis (FCGS), including its link to feline calicivirus, immune dysfunction, and current treatment options. It will present a new protocol using EIDD-1931, doxycycline, and meloxicam, with clinical outcomes, guidelines, common concerns, and welfare-based decision-making.

Understanding FCGS

Feline Chronic Gingivostomatitis (FCGS) is a painful, immune-mediated inflammatory condition of the oral mucosa in cats. Unlike regular gingivitis, FCGS involves ulcerative or proliferative lesions extending beyond the gingiva to the caudal oral cavity and pharynx.

The Culprit? Feline Calicivirus (FCV)

Research shows that FCGS is closely linked to FCV – a stubborn virus that causes persistent infection in the mouth. However, not all cats exposed to FCV develop this condition.

Minimize Invasive Extractions

This product can be used as part of the treatment of FCGS with precision using a simple, targeted, and feline-appropriate solution**.

It delivers both local and systemic action while adhering to oral tissues to support prolonged contact and enhanced efficacy. A single, innovative formulation designed to provide comprehensive performance.

New Thinking

This article dives into the evolving pathophysiology of FCGS and juvenile gingivitis and points toward novel, medically driven approaches.

Source: Richard Malik & Andrea Harvey Centre for Veterinary Education and Sydney School of Veterinary Science, The University of Sydney

For the Treatment of Feline Calicivirus (FCV)-associated FCGS

GingiPro™

Doxycycline (as monohydrate)/ EIDD-1931/Meloxicam

60 mg/204 mg/0.15 mg/mL

Chicken flavored oral paste, 30 mL pump

Also available: GingiPro Duo™(Doxycycline as monohydrate/EIDD-1931) and GingiPro Solo™ (EIDD-1931 alone), 30 mL pump

Stokes Pharmacy has formed an exclusive partnership with the Bova group to offer a U.S.-made oral treatment for FCGS. This treatment is supported by Bova’s unique drug formula, which has been utilized in Australia.

Dosing Guide (using Topi-CLICK dispenser)

Topi-CLICK Perl® 1 click= 0.25 mL

Weight	3 kg cat	4.5 kg cat	6 kg cat
Total Clicks Per Day	2 Clicks	3 Clicks	4 Clicks
Frequency	Twice Daily	Twice Daily	Twice Daily
Daily Dosing	1 click in the AM & 1 click in the PM	2 clicks in the AM 1 click in the PM or 1 click in the AM 2 clicks in the PM	2 clicks in the AM 2 clicks in the PM
Doxycycline/ EIDD-1931/ Meloxicam (strength per dose)	15 mg 51 mg 0.0375	22.5 mg 76.5 mg 0.05625 mg	30 mg 102 mg 0.075 mg

Standard Protocol (Bova Dose Rate)
Doxycycline: 5 mg/kg BID
EIDD-1931: 17 mg/kg BID
Meloxicam: 0.0125 mg/kg BID

Administration
Best: Apply directly to oral mucosa for high local drug
concentration. Full safety instructions are provided with the product.
Alternate: Can be mixed into wet food if direct dosing
is not tolerated.

Targeted Antiviral Action with a Multi-Drug Approach

EIDD-1931 is designed for immediate local action as an
antiviral, unlike molnupiravir, which requires liver activation
to become effective.
The combination of three medications improves healing and
immune regulation compared to using a single drug.
A low dose of meloxicam is maintained to prevent renal stress; ensuring hydration is crucial.
Guidance for owner handling can be viewed here and is also included with the prescribed medication.

**Important Notice: This product is not intended to treat common gingivitis; it is specifically formulated for
stomatitis associated with calicivirus. We strongly advise conducting a comprehensive evaluation to determine
if the gum inflammation spreads to the palate and the back of the throat before selecting an appropriate
prescription or considering alternative treatment options for the situation.